On 30 March 2022, Cengild Medical Berhad (Cengild) has just launched its IPO at 33 sen a share. Upon its listing, Cengild’s market capitalisation shall be lifted to RM 207.2 million. The application to its IPO shares will be closed on 5 April 2022. There are 9 things investors should know about Cengild Medical IPO as shown below:

#1 About Cengild Medical 

Cengild Medical runs a medical centre which specialises in the diagnosis and treatments of gastrointestinal and liver diseases and obesity in Kuala Lumpur. It had started its operation in October 2017 at Nexus @ Bangsar South with a built-up area of approximately 36,588 sq. ft. that houses 6 clinics, 10 inpatient beds, and as well as 1 operating theatre. Since then, Cengild has expanded its medical operations to 10 clinics, 28 inpatient beds, and 2 operating theatres as of 1 March 2022. #2 Financial Results Since commencement, Cengild had increased its number of brand new patients and surgeries performed significantly. For example, the number of surgeries jumped 7x from 210 to 1,450 in...